Skip to search.
 All Ordinaries Up 1.06%

More On NRT.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Novogen Ltd (NRT.AX)

-ASX
0.29 Down 0.02(4.92%) 29 May 16:10
Add to Portfolio
Prev Close:0.31
Open:0.30
Bid:0.29
Ask:0.30
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.29 - 0.30
52wk Range:0.08 - 0.45
Volume:2,039,720
Avg Vol (3m):7,173,560
Market Cap:104.69M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback